tiprankstipranks
Alphamab Oncology (HK:9966)
:9966
Hong Kong Market
9966
Alphamab Oncology
RESEARCH TOOLSreports
Want to see HK:9966 full AI Analyst Report?

Alphamab Oncology (9966) Income Statement

2 Followers

Alphamab Oncology Income Statement

Last quarter (Q4 2025), Alphamab Oncology's total revenue was ¥242.68M, an increase of 194.84% from the same quarter last year. In Q4, Alphamab Oncology's net income was ¥-133.25M. See Alphamab Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 551.58M¥ 640.08M¥ 218.77M¥ 166.84M¥ 146.02M
Gross Profit
¥ 426.67M¥ 579.77M¥ 163.54M¥ 122.64M¥ 142.99M
Operating Expenses
¥ 575.99M¥ 479.26M¥ 487.09M¥ 555.18M¥ 558.91M
Depreciation and Amortization
¥ 63.01M¥ 55.78M¥ 69.12M¥ 40.54M¥ 41.10M
EBITDA
¥ -86.31M¥ 156.79M¥ -129.30M¥ -391.83M¥ -358.13M
Operating Income
¥ -149.32M¥ 101.01M¥ -305.55M¥ -432.37M¥ -415.62M
Other Income/Expenses
¥ 38.33M¥ 65.84M¥ 112.96M¥ 106.82M¥ 3.50M
Pretax Income
¥ -110.99M¥ 166.34M¥ -210.59M¥ -325.72M¥ -412.42M
Net Income
¥ -110.99M¥ 166.34M¥ -210.59M¥ -325.72M¥ -412.42M
Per Share Metrics
Basic EPS
¥ -0.12¥ 0.17¥ -0.22¥ -0.35¥ -0.44
Diluted EPS
¥ -0.12¥ 0.17¥ -0.22¥ -0.35¥ -0.44
Weighted Average Shares Outstanding
 961.40M 978.48M 959.90M 930.63M 935.49M
Weighted Average Shares Outstanding (Diluted)
 961.40M 984.19M 959.90M 936.50M 935.49M
Currency in CNY

Alphamab Oncology Earnings and Revenue History